First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment

The new study published in Cancer Discovery, the flagship journal of the American Association of Cancer Research (AACR), involving three Spanish and six American research centres, presents significant results in treating cancer patients with nanoparticles containing ribonucleic acid interference (RNAi) molecules. This marks the first time that the therapeutic effect of RNAi has been demonstrated in humans.

Read the whole article on Biology News Net

More from Biology News Net